Abstract
The potential for radiomics to support oncology decision-making has grown substantially in recent years, as these scanning techniques have been found to offer unique information regarding the tumor phenotype and microenvironment that is distinct from that provided by genomic or proteomic assays. Radiomic and genomic (or proteomic) data can be correlated with one another, thereby facilitating radiogenomic efforts. Radiogenomically-informed biopsies have the potential to yield better pathological outcomes and can aid in the planning of more appropriate treatment strategies for cancer patients. However, the field lacks a unified software platform wherein radiomic and genomics/proteomic data could be brought together to conduct a variety of correlational analyses and build robust artificial intelligence models that would aid the prediction of genomic/proteomic profiles of tumors from their radiological images. We have built such a comprehensive platform that could be utilized by scientists and clinicians globally to conduct radiogenomic studies for a variety of cancer types, and further validate and deploy it in clinics to aid effective monitoring, diagnosis, and treatment of cancer patients.
Citation Format: Shrey S. Sukhadia, Shivashankar H. Nagaraj, Olivier Gevaert, Sivakumaran Theru Arumugam, Aayush Tyagi, Pritam Mukherjee, A.P. Prathosh. A sophisticated bioinformatics framework for integrative study of radiomics and genomics profiles of tumors [abstract]. In: Proceedings of the AACR Virtual Special Conference on Artificial Intelligence, Diagnosis, and Imaging; 2021 Jan 13-14. Philadelphia (PA): AACR; Clin Cancer Res 2021;27(5_Suppl):Abstract nr PO-036.
RSS Feeds